Incidence, management, and outcome of lung cancer in patients with long‐term oxygen therapy
Abstract Background Here, we aimed to assess the specific features of lung cancer in patients with long‐term oxygen therapy (LTOT), and compare their outcomes with patients suffering from lung cancer without LTOT. Methods This retrospective, case‐controlled study included patients with LTOT and an i...
Main Authors: | Timothée Lambert, Kinan El Husseini, Maeva Zysman, Boris Duchemann, André Gillibert, Luca Campedel, Edouard Dantoing, Camille Rolland‐Debord, Maxime Patout |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14692 |
Similar Items
-
Stereotactic body radiotherapy takes on Lung Oligometastases: Latest breakthroughs
by: Xin Liu, et al.
Published: (2024-06-01) -
Highlights on the Management of Oligometastatic Disease
by: Salem M. Alshehri, et al.
Published: (2020-02-01) -
Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
by: Robert Olson, et al.
Published: (2018-10-01) -
Treatment options for unilateral vestibular schwannoma: a network meta-analysis
by: Xianhao Huo, et al.
Published: (2024-12-01) -
Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control
by: Naoyuki Kanayama, et al.
Published: (2022-12-01)